Lateral flow tests (LFTs), also known as lateral flow immunoassays (LFIAs), are essential tools in modern diagnostics, celebrated for their speed, portability, and ease of use. These simple yet powerful devices have gained public recognition during the COVID-19 pandemic and have long been used for pregnancy testing. But their potential goes far beyond these two
Lateral Flow Tests: How they work and why they matter? Read More »
Rapid Diagnostic Tests (RDTs) provide quick, accurate results at the Point-of-Care or Point-of-Need, detecting biomarkers for infectious diseases and other conditions. Their portability and simplicity enhance early detection and accessibility in healthcare.
What is a Rapid Diagnostic Test (RDT)? Read More »
ALTERDIAG raised €2M in Seed funding to develop innovative Rapid Diagnostic Tests Paris, France, January 29, 2025 – ALTERDIAG, a private biotech company specializing in the development of rapid diagnostic tests targeting infectious disease pathogens, announces a €2 million seed funding round from Forepont Capital Partners, a New York-based venture capital firm specializing in healthcare
Press Release – raising seed funds Read More »
AlterDiag announces the signature of a strategic partnership with the Institut Pasteur
Press Release – strategic partnership with the Institut Pasteur Read More »
